Panel proposes sweeping changes to India's drug regulatory system
This article was originally published in Scrip
Executive Summary
An expert committee appointed by India's health ministry has recommended a range of reforms to India's drug regulatory system, including the creation of a "Central Accreditation Council" to oversee the accreditation of clinical investigators, institutes and their ethics committees, and a time and "assurance" bound system to decide on clinical trial applications in the country.